GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » EPS (Basic)

Duopharma Biotech Bhd (XKLS:7148) EPS (Basic) : RM0.07 (TTM As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd EPS (Basic)?

Duopharma Biotech Bhd's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was RM0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was RM0.07.

Duopharma Biotech Bhd's EPS (Diluted) for the three months ended in Dec. 2024 was RM0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was RM0.07.

Duopharma Biotech Bhd's EPS without NRI for the three months ended in Dec. 2024 was RM0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 0.07.

During the past 12 months, Duopharma Biotech Bhd's average EPS without NRIGrowth Rate was 18.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -2.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -0.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Duopharma Biotech Bhd's highest 3-Year average EPS without NRI Growth Rate was 26.00% per year. The lowest was -17.40% per year. And the median was 0.30% per year.


Duopharma Biotech Bhd EPS (Basic) Historical Data

The historical data trend for Duopharma Biotech Bhd's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd EPS (Basic) Chart

Duopharma Biotech Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.07 0.07 0.06 0.07

Duopharma Biotech Bhd Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.02 0.02 0.02 0.02

Duopharma Biotech Bhd EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Duopharma Biotech Bhd's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(62.645-0)/961.942
=0.07

Duopharma Biotech Bhd's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(15.083-0)/961.942
=0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Duopharma Biotech Bhd  (XKLS:7148) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Duopharma Biotech Bhd EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Duopharma Biotech Bhd Business Description

Traded in Other Exchanges
N/A
Address
Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, SGR, MYS, 41200
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd Headlines

No Headlines